title: Guidelines for safe practice of stereotactic body (ablative) radiation therapy.
abstract: The uptake of stereotactic ablative body radiation therapy (SABR)/stereotactic body radiation therapy (SBRT) worldwide has been rapid. The Australian and New Zealand Faculty of Radiation Oncology (FRO) assembled an expert panel of radiation oncologists, radiation oncology medical physicists and radiation therapists to establish guidelines for safe practice of SABR. Draft guidelines were reviewed by a number of international experts in the field and then distributed through the membership of the FRO. Members of the Australian Institute of Radiography and the Australasian College of Physical Scientists and Engineers in Medicine were also asked to comment on the draft. Evidence-based recommendations (where applicable) address aspects of departmental staffing, procedures and equipment, quality assurance measures, as well as organisational considerations for delivery of SABR treatments. Central to the guidelines is a set of key recommendations for departments undertaking SABR. These guidelines were developed collaboratively to provide an educational guide and reference for radiation therapy service providers to ensure appropriate care of patients receiving SABR.
authors.affiliation: Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
authors.forename: Matthew
authors.initials: M
authors.lastname: Foote
authors.affiliation: Department of Radiation Oncology Medical Physics, Illawarra Cancer Care Centre, Wollongong, New South Wales, Australia.
authors.forename: Michael
authors.identifier: http://orcid.org/0000-0002-1462-4143
authors.initials: M
authors.lastname: Bailey
authors.affiliation: William Buckland Radiotherapy Centre, The Alfred, Melbourne, Victoria, Australia.
authors.forename: Leigh
authors.initials: L
authors.lastname: Smith
authors.affiliation: Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
authors.forename: Shankar
authors.initials: S
authors.lastname: Siva
authors.affiliation: Central Coast Cancer Care Centre, Gosford, New South Wales, Australia.
authors.forename: Fiona
authors.initials: F
authors.lastname: Hegi-Johnson
authors.affiliation: William Buckland Radiotherapy Centre, The Alfred, Melbourne, Victoria, Australia.
authors.forename: Anna
authors.initials: A
authors.lastname: Seeley
authors.affiliation: Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
authors.forename: Tamara
authors.initials: T
authors.lastname: Barry
authors.affiliation: Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.|Institute of Medical Physics, School of Physics, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Booth
authors.affiliation: Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.|The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Ball
authors.affiliation: Institute of Medical Physics, School of Physics, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Thwaites
mesh_terms: D001315:Australia; D008495:Medical Oncology / Q000592:standards*; D009520:New Zealand; D061214:Patient Safety / Q000592:standards*; D017410:Practice Guidelines as Topic; D011834:Radiation Monitoring / Q000592:standards*; D011835:Radiation Protection / Q000592:standards*; D016634:Radiosurgery / Q000592:standards*
keywords: ablative radiation therapy; guideline; quality assurance; radiation oncology; stereotactic body